Forest Laboratories, Inc. has announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII) are now available to physicians and pharmacies in US.
Combunox was approved by the US FDA on November 26, 2004, for the short-term (no more than seven days) management of acute, moderate to severe pain. Combunox is the first and only product to combine 5 mg of oxycodone HCl and 400 mg of ibuprofen, which is the highest dose of ibuprofen available in a combination opioid product.
Howard Solomon, chairman and CEO of Forest Laboratories said, "It is an effective and well-tolerated medication for the millions of Americans who need acute pain control following injury or surgery."